Sunday 18 October 2026
Export SEER’s income statement to Excel — free account
Seer, Inc.
SEER Healthcare Biotechnology
Seer, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.6 million, up 17.0% from fiscal 2024. In the quarter to June 2026, revenue fell 23.4%, EPS grew 6.06% and free cash flow grew 36.7%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
2.03
0.01
−0.49%
Follow SEER
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 4 | 5 | 5 |
+8 more TTM periods Free account |
| (26.45%) | (25.52%) | (25.08%) | (25.74%) | ||
| (23.47%) | (22.76%) | (22.21%) | (22.93%) | ||
ROIC |
(60.78%) | (62.26%) | (66.40%) | (72.42%) | |
Return on Tangible Assets |
(40.70%) | (38.14%) | (36.69%) | (36.94%) | |
Average Days of Receivables |
88.11 | 102.43 | 131.05 | 114.94 | |
Free Cash Flow per Share |
(0.80) | (0.88) | (0.79) | (0.80) | |
Free Cash Flow |
(43.98) | (49.53) | (45.60) | (45.08) | |
Capital Expenditures |
(0.60) | (1.07) | (1.15) | 0.02 | |
| Other line items | |||||
Cash ROIC |
(11.62%) | (12.14%) | (10.24%) | (9.57%) | |
Accounts Receivable Turnover |
3.11 | 3.16 | 2.72 | 2.82 | |
Accounts Payable Turnover |
2.55 | 2.24 | 1.59 | 3.23 | |
Inventory Turnover |
0.98 | 1.03 | 1.07 | 1.07 | |
Average Days of Payables |
155.16 | 117.15 | 252.44 | 192.72 | |
Days of Inventory on Hand |
376.14 | 379.03 | 350.69 | 367.53 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
264.15% | 272.52% | 264.65% | 285.47% | |
Selling, General and Administrative Expense of Revenue |
281.74% | 267.53% | 256.86% | 278.75% | |
Share Based Compensation of Revenue |
74.35% | 84.91% | 92.98% | 113.37% | |
Operating CF/Net income |
0.64 | 0.69 | 0.60 | 0.57 | |
Depreciation/Fixed assets |
0.56 | 0.51 | 0.49 | 0.53 | |
Capex/Depreciation |
(0.09) | (0.16) | (0.16) | 0.00 | |
Revenue per Share |
0.26 | 0.27 | 0.29 | 0.29 | |
Operating CF per Share |
(0.79) | (0.87) | (0.77) | (0.80) | |
Capex per Share |
(0.01) | (0.02) | (0.02) | 0.00 | |
Capex to Sales |
0.04 | 0.07 | 0.07 | 0.00 |
Columns are period end dates